RFW
HRTX icon

Redwood Family Wealth’s Heron Therapeutics HRTX Stock Holding History

Redwood Family Wealth’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45K Buy
105,472
+40,972
+64% +$32.9K 0.04% 109
2026
Q1 		$51.6K Hold
64,500
– – 0.05% 99
2025
Q4 		$83.8K Buy
+64,500
New +$79.6K 0.08% 103

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Redwood Family Wealth's HRTX Position: Q2 2026 in Review

Redwood Family Wealth increased its Heron Therapeutics (HRTX) stake by 64% in Q2 2026, buying an estimated $32.9K and bringing the position to 105,472 shares worth $45K. The position accounts for 0.04% of the portfolio, ranked #109.

Redwood Family Wealth first reported a position in HRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $83.8K in Q4 2025. 161 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Redwood Family Wealth held 105,472 shares of Heron Therapeutics worth $45K as of Q2 2026.
  • Redwood Family Wealth bought 40,972 Heron Therapeutics shares in Q2 2026, an estimated $32.9K.
  • Heron Therapeutics made up 0.04% of Redwood Family Wealth's portfolio in Q2 2026, its #109 holding.
  • Redwood Family Wealth first reported a position in Heron Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Redwood Family Wealth's Heron Therapeutics position peaked at $83.8K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Redwood Family Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.